1 enrolling by invitation, 1 not yet recruiting, 1 no longer available, 1 recruiting. 3 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Withdrawn 1 |
| Phase 1 | 1 | Enrolling by invitation 1 |
Follow Graft-Versus-Host Disease(GVHD): new trials by email Literature Review of Graft-Versus-Host Disease(GVHD) trials Research Report on Graft-Versus-Host Disease(GVHD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC - Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD) | Phase 2 | Not yet recruiting | Instituto de Investigación Biomédica de Salamanca | 30 | 2026-10-01 | 2026-09-03 |
| Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors Low-dose ATG + PTCy + Ivarmacitinib - Graft-Versus-Host Disease(GVHD), Bone Marrow Transplantation | Phase 2 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 82 | 2026-05-01 | 2026-05-06 |
| 5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD) 5-Azacytidine - Graft-Versus-Host Disease(GVHD) | Early Phase 1 | Withdrawn | Baylor College of Medicine | 2025-08-01 | 2025-09-22 | |
| Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation. Omega-3 Lipid Emulsion - Graft-Versus-Host Disease(GVHD) | Phase 1 / Phase 2 | Enrolling by invitation | Fujian Medical University | 30 | 2025-05-16 | 2025-11-18 |
| CliniMACS® CD34+ Reagent System for Expanded Access Use CliniMACS CD34 Reagent System - Graft-Versus-Host Disease(GVHD), Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem Cells | No longer available | Joseph Antin | 2013-03-01 | 2016-11-21 |
Graft vs Host Disease (5) · Delayed Graft Function (1) · Dry Eye Syndromes (1)
Immune System Diseases (5) · Eye Diseases (1) · Lacrimal Apparatus Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Azacitidine (1) · Docosahexaenoic Acids (1) · ivarmacitinib (1)
Baylor College of Medicine (1) · Fujian Medical University (1) · Instituto de Investigación Biomédica de Salamanca (1) · Joseph Antin (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (2) · United States (2)
Helen Heslop, MD (1) · Mi Kwon MD, PhD, Medical Degree in Haematology (1) · Sarah Nikiforow, MD, PhD (1) · Ting Yang, MD, PhD (1) · Xianmin Song, PhD (1)